Italian family with two independent mutations: 3358T/A in BRCA1 and 8756delA in BRCA2 genes
- PMID: 12673274
- DOI: 10.1038/sj.ejhg.5200948
Italian family with two independent mutations: 3358T/A in BRCA1 and 8756delA in BRCA2 genes
Abstract
Hereditary breast/ovarian cancer is a well-characterized clinical entity, largely attributed to the inheritance of BRCA1 or BRCA2 mutations. Among general population, the mutation's frequency of these genes is very low; therefore, the identification of two independent mutations in the same family is a rare event. This study reports the presence of two mutations, one in the BRCA1 and the second in the BRCA2 gene in an Italian Caucasian kindred. This family is composed of more than 250 individuals, spanning through five generations, among which endogamy was a common phenomenon. Considering the tumor spectrum, this family is characterized by a high incidence of different types of cancer. In our study, we considered only three out of seven family units for BRCA1 and BRCA2 analysis. In one of the family units, we found independent mutations of both BRCA genes. The BRCA1 mutation on exon 11 (3358T-->A) was identified originally in the index case and subsequently in 18 members of this family, whereas the same mutation was not detected in a related family member with male breast cancer. The male breast cancer patient led to the identification, through mutational analysis, of a new BRCA2 mutation (8756delA). This BRCA2 mutation was also found in the male breast cancer patient's daughter. The discovery of the BRCA2 mutation allowed us to alert the patient's daughter who, otherwise, could be falsely reassured since she had a negative BRCA1 test.
Similar articles
-
Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.Hum Mutat. 2003 Aug;22(2):121-8. doi: 10.1002/humu.10238. Hum Mutat. 2003. PMID: 12872252
-
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.J Natl Cancer Inst. 2006 Dec 6;98(23):1694-706. doi: 10.1093/jnci/djj465. J Natl Cancer Inst. 2006. PMID: 17148771
-
Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.Breast Cancer Res Treat. 2006 Jan;95(1):81-7. doi: 10.1007/s10549-005-9047-1. Epub 2005 Oct 27. Breast Cancer Res Treat. 2006. PMID: 16261400
-
Hereditary breast-ovarian cancer: clinical findings and medical management.Plast Surg Nurs. 2007 Jul-Sep;27(3):124-7. doi: 10.1097/01.PSN.0000290280.48197.e7. Plast Surg Nurs. 2007. PMID: 17901820 Review.
-
BRCA1, BRCA2 and breast cancer: a concise clinical review.Clin Invest Med. 2001 Jun;24(3):147-57. Clin Invest Med. 2001. PMID: 11437066 Review.
Cited by
-
A Novel Mutation-BRCA1 Associated Hereditary Haplotype of Intragenic Markers of BRCA1 Gene in a Family with History of Breast Cancer.Asian Pac J Cancer Prev. 2019 Feb 26;20(2):611-614. doi: 10.31557/APJCP.2019.20.2.611. Asian Pac J Cancer Prev. 2019. PMID: 30806067 Free PMC article.
-
Origin and distribution of the BRCA2-8765delAG mutation in breast cancer.BMC Cancer. 2007 Jul 19;7:132. doi: 10.1186/1471-2407-7-132. BMC Cancer. 2007. PMID: 17640379 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous